Attached files

file filename
EX-99.2 - Sonnet BioTherapeutics Holdings, Inc.ex99-2.htm
EX-99.1 - Sonnet BioTherapeutics Holdings, Inc.ex99-1.htm

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): May 19, 2016

 

CHANTICLEER HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 Delaware   001-35570   20-2932652
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification)

 

7621 Little Avenue, Suite 414, Charlotte, NC 28226

(Address of principal executive office) (zip code)

 

 

 

(Former address of principal executive offices) (zip code)

 

(704) 366-5122
(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

 

 

 

 
 

 

ITEM 2.02. Results of Operations and Financial Condition.

 

On May 17, 2016, Chanticleer Holdings, Inc. issued a press release announcing its first quarter 2016 results. A copy of the press release is furnished not filed as Exhibit 99.1 hereto. In addition, the Company is filing an investor presentation filed as Exhibit 99.2 hereto.

 

The information in this Item 2.02,  including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 

 

ITEM 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

  99.1 Press release dated May 17, 2016.
     
  99.2 Investor presentation dated May 17, 2016.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 19, 2016

 

  Chanticleer Holdings, Inc.
     
  By: /s/ Michael D. Pruitt
    Michael D. Pruitt
    Chief Executive Officer

 

 
 

 

EXHIBIT INDEX

 

Exhibit No.   Description    Manner of Filing
         
99.1   Press Release dated May 17, 2016   Furnished Electronically
         
99.2   Investor presentation dated May 17, 2016   Furnished Electronically